Abbott Laboratories (ABT) Amortizatization of Intangibles (2017 - 2018)

Abbott Laboratories (ABT) reported Amortizatization of Intangibles of $32.0 million for Q1 2018, down 91.84% on a YoY basis from $392.0 million in Q1 2017, and down 52.24% sequentially from $67.0 million in Q4 2017.

Abbott Laboratories (ABT) Amortizatization of Intangibles (2017 - 2018) Analysis & Trends

Abbott Laboratories (ABT) has 2 years of Amortizatization of Intangibles data on file, last reported at $32.0 million in Q1 2018.

  • For the quarter ending Q1 2018, Amortizatization of Intangibles fell 91.84% year-over-year to $32.0 million; the trailing twelve-month figure through Dec 2018 stood at $32.0 million (down 96.48% YoY), and the FY2018 full-year result was $32.0 million, down 96.47% from the prior year.
  • Amortizatization of Intangibles eased to $32.0 million in Q1 2018, from $67.0 million in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $430.0 million in Q2 2017 to a low of $20.0 million in Q3 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -
10 Steris 21.47 Bn 21.03 Bn 697.10 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2018 32.00 Mn
Mar 31, 2018 32.00 Mn
Dec 31, 2017 67.00 Mn
Dec 31, 2017 67.00 Mn
Sep 30, 2017 20.00 Mn
Sep 30, 2017 20.00 Mn
Jun 30, 2017 430.00 Mn
Jun 30, 2017 430.00 Mn
Mar 31, 2017 392.00 Mn
Mar 31, 2017 392.00 Mn